124 related articles for article (PubMed ID: 18640268)
1. In vitro release of propofol and binding capacity with regard to plasma constituents.
Schicher M; Polsinger M; Hermetter A; Prassl R; Zimmer A
Eur J Pharm Biopharm; 2008 Nov; 70(3):882-8. PubMed ID: 18640268
[TBL] [Abstract][Full Text] [Related]
2. 'In vitro' binding of propofol to serum lipoproteins in thyroid dysfunction.
de la Fuente L; Lukas JC; Vázquez JA; Jauregizar N; Calvo R; Suárez E
Eur J Clin Pharmacol; 2002 Dec; 58(9):615-9. PubMed ID: 12483454
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of new propofol aqueous solutions for intravenous anesthesia.
Trapani A; Laquintana V; Lopedota A; Franco M; Latrofa A; Talani G; Sanna E; Trapani G; Liso G
Int J Pharm; 2004 Jun; 278(1):91-8. PubMed ID: 15158952
[TBL] [Abstract][Full Text] [Related]
4. Binding of propofol to human serum albumin.
Schywalsky M; Ihmsen H; Knoll R; Schwilden H
Arzneimittelforschung; 2005; 55(6):303-6. PubMed ID: 16032968
[TBL] [Abstract][Full Text] [Related]
5. Differences of propofol concentrations in mammalian whole blood and in corresponding plasma samples analyzed by high performance liquid chromatography.
Grossherr M; Spies E; Scheel A; Hengstenberg A; Gehring H; Dibbelt L
Clin Lab; 2007; 53(5-6):315-9. PubMed ID: 17605407
[TBL] [Abstract][Full Text] [Related]
6. Direct assessments of the antioxidant effects of propofol medium chain triglyceride/long chain triglyceride on the brain of stroke-prone spontaneously hypertensive rats using electron spin resonance spectroscopy.
Kobayashi K; Yoshino F; Takahashi SS; Todoki K; Maehata Y; Komatsu T; Yoshida K; Lee MC
Anesthesiology; 2008 Sep; 109(3):426-35. PubMed ID: 18719440
[TBL] [Abstract][Full Text] [Related]
7. Propofol binding to human blood proteins.
Altmayer P; Büch U; Büch HP
Arzneimittelforschung; 1995 Oct; 45(10):1053-6. PubMed ID: 8595056
[TBL] [Abstract][Full Text] [Related]
8. Influence of propofol concentration in human plasma on free fraction of the drug.
Dawidowicz AL; Kalitynski R; Kobielski M; Pieniadz J
Chem Biol Interact; 2006 Feb; 159(2):149-55. PubMed ID: 16318847
[TBL] [Abstract][Full Text] [Related]
9. Influence of intralipid on free propofol fraction assayed in human serum albumin solutions and human plasma.
Kalitynski R; Dawidowicz AL; Poszytek J
Acta Pharmacol Sin; 2006 Dec; 27(12):1637-41. PubMed ID: 17112420
[TBL] [Abstract][Full Text] [Related]
10. A propofol microemulsion with low free propofol in the aqueous phase: formulation, physicochemical characterization, stability and pharmacokinetics.
Cai W; Deng W; Yang H; Chen X; Jin F
Int J Pharm; 2012 Oct; 436(1-2):536-44. PubMed ID: 22814221
[TBL] [Abstract][Full Text] [Related]
11. The significance of lipoproteins in serum binding variations of propofol.
Zamacona MK; Suárez E; García E; Aguirre C; Calvo R
Anesth Analg; 1998 Nov; 87(5):1147-51. PubMed ID: 9806699
[TBL] [Abstract][Full Text] [Related]
12. Effect of Lipid Composition in Propofol Formulations: Decisive Component in Reducing the Free Propofol Content and Improving Pharmacodynamic Profiles.
Darandale SS; Shevalkar GB; Vavia PR
AAPS PharmSciTech; 2017 Feb; 18(2):441-450. PubMed ID: 27055535
[TBL] [Abstract][Full Text] [Related]
13. Distribution of Brevetoxin to Lipoproteins in human plasma.
Woofter RT; Ramsdell JS
Toxicon; 2007 Jun; 49(7):1010-8. PubMed ID: 17395229
[TBL] [Abstract][Full Text] [Related]
14. The effect of nimodipine, fentanyl and remifentanil intravenous products on the stability of propofol emulsions.
Nemec K; Germ E; Schulz-Siegmund M; Ortner A
Pharmazie; 2009 Feb; 64(2):94-7. PubMed ID: 19320281
[TBL] [Abstract][Full Text] [Related]
15. Anomalous relationship between free drug fraction and its total concentration in drug-protein systems I. Investigation of propofol binding in model HSA solution.
Dawidowicz AL; Kobielski M; Pieniadz J
Eur J Pharm Sci; 2008 May; 34(1):30-6. PubMed ID: 18374549
[TBL] [Abstract][Full Text] [Related]
16. Binding of propofol to blood components: implications for pharmacokinetics and for pharmacodynamics.
Mazoit JX; Samii K
Br J Clin Pharmacol; 1999 Jan; 47(1):35-42. PubMed ID: 10073737
[TBL] [Abstract][Full Text] [Related]
17. HPLC investigation of free and bound propofol in human plasma and cerebrospinal fluid.
Dawidowicz AL; Kalityński R
Biomed Chromatogr; 2003 Oct; 17(7):447-52. PubMed ID: 14598328
[TBL] [Abstract][Full Text] [Related]
18. Rapid dissolution of propofol emulsions under sink conditions.
Damitz R; Chauhan A
Int J Pharm; 2015 Mar; 481(1-2):47-55. PubMed ID: 25636303
[TBL] [Abstract][Full Text] [Related]
19. Kinetics and thermodynamics of lipid amphiphile exchange between lipoproteins and albumin in serum.
Estronca LM; Moreno MJ; Laranjinha JA; Almeida LM; Vaz WL
Biophys J; 2005 Jan; 88(1):557-65. PubMed ID: 15465860
[TBL] [Abstract][Full Text] [Related]
20. [Investigation of conjugation and metabolism of propofol with the method of high performance liquid chromatography].
Adeishvili-Andguladze LV; Makharadze RV; Kurtsikidze MSh; Abuladze NB; Gabuniia KU
Georgian Med News; 2009 Apr; (169):98-100. PubMed ID: 19430056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
